Ivan Ashton, DPM
Foot Surgery · Dallas, TXNPI 1497804678
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $748 of the $1,120 with a category attached, or 66.8%. 11 manufacturers reported payments, led by DJO, LLC at 33.2% of the total. That places this record below the midpoint for foot surgery clinicians in TX, where the typical reported total is $2,095.
Across 43 payments — averaging $26.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- DJO, LLC$372
- Sandoz$181
- Sebela Pharmaceuticals Inc.$158
- Orthofix Medical, Inc.$123
- Amgen$111
- Journey Medical Corporation$63
- plus $111 from 5 others
What the payments were for
- Food & beverage$74867%
- Education$37233%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| DJO, LLC | 6 | $372 |
| Sandoz | 11 | $181 |
| Sebela Pharmaceuticals Inc. | 10 | $158 |
| Orthofix Medical, Inc. | 1 | $123 |
| Amgen | 6 | $111 |
| Journey Medical Corporation | 3 | $63 |
| Hikma Pharmaceuticals USA | 2 | $30 |
| Integra Lifesciences Corporation | 1 | $25 |
| Alfasigma USA, Inc. | 1 | $20 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $19 |
| Forte Bio-pharma LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DR COMFORT$218
- Physio-Stim$123
How this compares
$1,120 in reported general payments places this provider in the 30th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 25 | $798 |
| CiclopiroxCiclopirox Olamine | 23 | $508 |
| Terbinafine Hcl | 67 | $442 |
| Meloxicam | 116 | $402 |
| Gabapentin | 42 | $390 |
| Ciprofloxacin Hcl | 23 | $160 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $114 |
| Amoxicillin | 25 | $90 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Dallas
- Richard GalperinDallas$12K
- Richard WeinerDallas$11K
- Jon NathansonDallas$2K
- Darlene CarterDallas$2K
- Roy AshtonDallas$707
- Scott AshtonDallas$381
- Marque AllenSan Antonio$204K
- James JacobsKaty$81K
- Lawrence LaverySan Antonio$59K
- Robert GraserBoerne$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.